Home > slashdot > Startup Tests Drugs Aimed at Autism

Startup Tests Drugs Aimed at Autism

January 11th, 2010 01:52 admin Leave a comment Go to comments

An anonymous reader sends in this link from Technology Review about a startup company testing drugs that may help those with autism-spectrum disorders — even adults. “Seaside Therapeutics, a startup based in Cambridge, MA, is testing two compounds for the treatment of fragile X syndrome, a rare, inherited form of intellectual disability linked to autism. The treatments have emerged from molecular studies of animal models that mirror the genetic mutations seen in humans. Researchers hope that the drugs, which are designed to correct abnormalities at the connections between neurons, will ultimately prove effective in other forms of autism spectrum disorders. … The company is funded almost entirely by an undisclosed family investment of $60 million, with $6 million from the National Institutes of Health. [A spokesman] says that Seaside has enough funding to take its compounds through clinical testing and approval.”

Source: Startup Tests Drugs Aimed at Autism

Related Articles:

  1. Doctors Reverse With Drugs Autism-Linked Fragile X Syndrome
  2. Doctors Reverse With Drugs Autism-Linked Fragile X Syndrome In Mice
  3. Testing for Many Designer Drugs At Once
  4. Workers On Autism Spectrum Finding Careers In Software Testing
  5. Autism Traits Prove Valuable for Software Testing
blog comments powered by Disqus
YOYOYOOYOYOYO